|
⚲
|
| Keyboard |
| Callos Andrew
✚
|
|
|---|---|
| CIK # | 0001852129 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001852129] | |
| 4 | [0001852129] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cytokinetics Inc | |
| Callos Andrew |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-31 | Sell | 3,639 | $65.00 | 236,535 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-18 | Sell | 1,930 | $62.07 | 119,795 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-17 | Sell | 2,916 | $62.15 | 181,229 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-17 | Sell | 5,626 | $62.15 | 349,656 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-16 | Sell | 1,709 | $61.03 | 104,300 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-15 | Grant | 20,646 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-15 | Grant | 13,320 | $0.00 | |
|
Cytokinetics Inc CYTK
Incentive Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 1,665 | $0.00 | |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-15 | Grant | 29,480 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-09 | Sell | 2,582 | $60.72 | 156,779 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-05 | Option exercise | 11,000 | $39.13 | 430,430 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-05 | Sell | 15,000 | $61.87 | 928,050 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-05 | Sell | 11,000 | $61.88 | 680,680 |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-05 | Option exercise | 11,000 | $0.00 | |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-03-05 | Option exercise | 15,000 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-05 | Option exercise | 15,000 | $23.26 | 348,900 |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-02 | Option exercise | 886 | $37.63 | 33,340 |
|
Cytokinetics Inc CYTK
Incentive Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 886 | $0.00 | |
|
Cytokinetics Inc CYTK
Common Stock
|
2026-03-02 | Sell | 886 | $61.62 | 54,595 |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2026-02-05 | Option exercise | 15,000 | $0.00 | |
| showing 20 of 84 most recent transactions | |||||